GlassScriptPhysician profile
Lauren Stoeckmann
NPI 1912560012
$2,651.43
in general payments reported to CMS, 2019-2025
24 companies · $690 in 2025
The $690 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $387 · 2023: $518 · 2024: $892 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $534.62 | 2023-2025 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $491.32 | 2023-2025 | Gemtesa |
| Glaxosmithkline, LLC. | $299.17 | 2021-2022 | |
| Janssen Biotech, INC. | $216.17 | 2023-2025 | Erleada, Akeega, Rybrevant |
| Abbvie INC. | $188.85 | 2023-2024 | |
| Optinose US, INC. | $161.60 | 2022 | |
| Astellas Pharma US INC | $144.75 | 2023-2025 | Xtandi, Myrbetriq |
| Endo USA, INC. | $112.14 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $96.19 | 2024-2025 | |
| Medtronic, INC. | $62.48 | 2021-2022 | |
| Accord Healthcare, INC. | $46.18 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $33.83 | 2023 | Provenge |
| Merck Sharp & Dohme LLC | $28.43 | 2023 | Lynparza, Keytruda |
| Regeneron Healthcare Solutions, INC. | $28.16 | 2022 | |
| Progenics Pharmaceuticals, INC. | $27.78 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $27.67 | 2023 | Xgeva |
| 180 Medical, INC. | $27.19 | 2024 | Gentlecath |
| Olympus America INC. | $21.79 | 2025 | Itind System |
| Angiodynamics, INC. | $19.15 | 2024 | Nanoknife |
| Bayer Healthcare Pharmaceuticals INC. | $18.98 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.71 | 2023 | Faslodex |
| Novartis Pharmaceuticals Corporation | $17.80 | 2025 | |
| Tolmar, INC. | $15.10 | 2023 | |
| Myriad Genetic Laboratories, INC. | $13.37 | 2023 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Stoeckmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.